NEW PRODUCTS

The Dx Pipeline: A Roundup of the Month’s Key New Product Launches

Here's a summary of the key product launches announced from late July through the third week of August, 2019: NEWLY LAUNCHED PRODUCTS & … [Read more...]

DIAGNOSTIC DEALS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Big picture-wise, health care industry mergers and acquisitions during the second quarter were up 7.3% from the first quarter and topped 250 deals for the eighth quarter in a row, according to … [Read more...]

REVENUES

DX Earnings Report: Markets Soften, Payors Harden but Growth Continues

Lab business is getting tougher. While PAMA cuts are hurting Medicare revenues, pressure from private payors may be even more intense both at the pricing front end and claims denial back end. Economic … [Read more...]

ENFORCEMENT

Investment Returns on the Federal Enforcement Dollar Continue to Drop

The business of enforcing federal health care fraud laws isn't as robust as it used to be. While revenues have remained pretty steady, return on investment (ROI) has been trending downward, providing … [Read more...]

SAFETY

Business Trends: Commercial Testing Companies ‘Sell’ Health Screenings

Several companies market an array of preventive tests directly to consumers. Are these companies and tests legit? What does the medical community have to say about such companies and advertising … [Read more...]

NEW PRODUCTS

The Dx Pipeline: A Roundup of the Month’s Key New Product Launches

A team led by Johns Hopkins Kimmel Cancer Center announced that it has developed a new test capable of determining whether patients with pancreatic cysts do or do not need surgery or further … [Read more...]

FDA

FDA Watch: Agency Issues New Guidance on Biotin Interference Testing

On June 13, the FDA issued a draft guidance explaining how makers of in vitro diagnostic devices (IVDs) should perform biotin interference testing and communicate testing results to labs, clinicians … [Read more...]

OIG OPINION

Is Your Billing Company Putting You At Compliance Risk?

By Sean McSweeney  bio Does your orthopedic billing company charge a percentage of collections for their coding and billing? They might break out separate charges for statements or other … [Read more...]

DIAGNOSTIC DEALS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

The strategic deal making pot continues to boil, despite the relative inactivity of the established market leaders like Quest, LabCorp and Abbott. Here's a look at the trends and major deals from late … [Read more...]

MARKETING

Dealing with Consumers: Using Patient Online Reviews to Boost Your Lab Business

Patients are making increasing use of physician rating and review sites to comment on their medical experiences the way diners do with restaurants. And as with restaurants, this can be a tremendous … [Read more...]


(-00000g2)